Ceterix Orthopaedics, Inc. develops novel surgical tools for arthroscopic procedures. The Ceterix technology enables surgeons to place stitches in very tight joint compartments, while protecting sensitive surrounding structures such as nerves, arteries and cartilage. This technology has applications in numerous arthroscopic procedures in knees, hips and shoulders. Ceterix was established in October 2010. The company was founded based on the inventions of Dr. Justin Saliman, an orthopaedic surgeon specializing in sports medicine. Dr. Saliman envisioned improving the outcomes of arthroscopic procedures by enabling surgeons to place suture patterns that today can be done only in open procedures, if at all. Ceterix is based in Menlo Park, California.

Bionx Implants, Inc. (the "Company") is a leading developer, manufacturer and marketer of Self-Reinforced, resorbable polymer implants, including screws, pins, arrows and stents, for use in a variety of applications which include orthopaedic surgery, urology, dentistry and maxillo-facial surgery.

Spinal Simplicity designs, develops, and sells percutaneously inserted interspinous inter-laminar fusion devices for the treatment of spinal problems to customers in the European Union. It offers Minuteman, an interspinous inter-laminar fusion device that provides relief from spinal ailments, such as spondylolisthesis, central and foraminal lumbar stenosis, and degenerative disc diseases. The company sells its products through distributors. Spinal Simplicity was founded in 2008 and is headquartered in Overland Park, Kansas.

Part of Medtronic Plc, Covidien Pte Ltd. is a Singaporean company located in Singapore that manufactures and supplies medical equipment.

Ethicon, Inc. is a subsidiary of Johnson & Johnson. It was incorporated as a separate company under the Johnson & Johnson umbrella in 1949 to expand and diversify the Johnson & Johnson product line. Ethicon has manufactured surgical sutures and wound closure devices since 1887. After World War II, Ethicon's market share in surgical sutures rose from 15% to 70% worldwide. In the United States, the market share is approximately 80%.

DePuy Orthopaedics, Inc. engages in the design, manufacture, and distribution of orthopedic devices and supplies. Its products are used primarily by orthopedic medical specialists and spinal neurosurgeons in both surgical and non-surgical therapy. The company was founded on December 13, 2016 and is headquartered in Warsaw, IN.

Meniscus injury can be severely debilitating and may lead to osteoarthritis and the need for knee arthroplasty. Today’s treatment options are limited resulting in a high unmet need. As for example, partial meniscectomy does not restore full joint biomechanics and is thought to lead to knee osteoarthritis. Partial replacement is only suitable as long as the meniscal rim is intact. Allograft transplantation has severe limitations including donor availability, risk of infection and sizing.

Yuhuan Hanpu Valve Co., Ltd., established on 2010-11-09, Business scope includes valves,Plumbing fittings,cleaning tools,Manufacturing and sales of fasteners,Import and export,Technology Import and Export.

Oxford Biomaterials' (OBM) mission is to establish a worldwide market for Spidrex and Silk Purifying technologies and to offer the Silk Life Cycle Analysis service. OBM is furthering this aim through licensing its products for specific applications and forming joint ventures while continuing to develop novel silk-based devices in-house. To date OBM has spun out three companies which are developing medical devices. It is developing a Silk Life Cycle Analysis service to confirm the quality and sustainability of silk products.

Amethyst (Shanxi) Regenerative Medicine Technology Co., Ltd., established on 2020-04-15, Business scope includes technological development of regenerative medicine technology(Does not contain medical diagnoses);Technology development of cosmetics;sales of cosmetics;Medical device management;food business;Beauty Information Consulting Service;beauty service;Technology development of computer software,Technology Promotion.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Xiamen Rigorer Sporting Goods Co., Ltd. (doing business as Rigorer) is a Chinese company located in Xiamen. The firm manufactures and retails sporting products. It was founded in 2014 by Ting Ting Hunag. Chen Yao Lin is the current CEO of the firm.

Founded to commercialise technology developed at Oxford University, Orthox aims to revolutionise the way cartilage injuries are treated. Trauma and erosion of the smooth, stiff cartilage in our joints leads to Osteoarthritis (OA) a debilitating disease, which affects over 300 million patients globally and costs the US economy alone over $128 billion each year. Current therapies to repair damaged cartilage focus either on tissue regeneration or on functional replacement; Orthox’s exceptionally strong, resilient, regenerative hydrogel technology, FibroFix™ achieves both these goals, offering a unique solution for the millions of patients suffering from damage to their joints. Initially targeting the knee, Orthox has developed a compelling set of data on lead product FibroFix™ Cartilage which has secured major awards from multiple funding bodies and will shortly enter clinical trials. FibroFix™ technology will then be rolled out to treat other joints and Orthox also has pipeline developments beyond orthopaedics in which strength and tissue regeneration are key. Pipeline expansion is valuable as growth in the annual global biomaterials market will exceed $250 billion by 2025. Orthopaedic biomaterials will form the largest proportion of this and natural biomaterials, like FibroFix™, will be the fastest growing market segment. Orthox: Reducing Pain, Increasing Mobility, Regenerating Strength™.

Beijing Jishuitan Hospital (JST Hospital; simplified Chinese: 北京积水潭医院; traditional Chinese: 北京積水潭醫院), is a large-scaled first-level hospital in Beijing, focusing mainly on orthopaedics and burn surgery. Founded in 1956, the hospital now has around 1000 beds. Its performance in medical care, teaching and researching led to it becoming the Fourth Medical College of Peking University. The hospital now has 200 doctors and 2200 other staff. The hospital has fully equipped departments of orthopaedics, spine surgery, adult joint reconstructive surgery, orthopaedic trauma, hand surgery, paediatric orthopaedics, bone tumor, sports medicines and burn surgery.

Shanghai Huoer Biotechnology Co., Ltd., established on 2016-10-08, Business scope includes technology development in the field of biotechnology,Technical Services,technology transfer,technical consulting(remove human stem cells,Development and application of genetic diagnosis and treatment technology),medicine,Health products,food research and development,Engaged in the import and export of goods and technology,food circulation. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

United States Surgical Corporation manufactures and markets wound closure products and advanced surgical devices. The company’s divisions include the Auto Suture, which offers surgical devices and laparoscopic instrumentation for general and specialty procedures; the Syneture Division that provides sutures and biosurgery products; and USS Sports Medicine, that offers spinal fixation and sports medicine products.

Quanzhou Mingyi Electronic Commerce Co., Ltd., established on 2011-07-22, Business scope includes general items:internet sales(Except for products that require a license for sale);Wholesale of sporting goods and equipment;Sporting Goods and Equipment Retailing;Clothing and apparel wholesale;Clothing and apparel retail;Wholesale shoes and hats;Shoes and hats retail;luggage sales;Home Appliance Sales;Office Supplies Sales;Outdoor product sales;General merchandise sales;Wholesale of computer software, hardware and auxiliary equipment;Retailing of computer software, hardware and auxiliary equipment;software development;software sales;Network technology service;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Innovasive Devices, Inc. designs, develops, manufacturers and markets proprietary tissue repair systems which facilitate the repair of soft tissue injuries. Its tissue repair systems are designed to be used in either open surgical or minimally invasive arthroscopic procedures. The company was founded in 1990 and is headquartered in Marlborough, MA.

Tissue Regenix was established in May 2006, to commercialize innovative technologies in regenerative medicine. The underpinning science was developed over the last decade in the world-leading Institute for Medical and Biological Engineering at the University of Leeds by Professors John Fisher and Eileen Ingham. The research has received in excess of £4 million grant funding to date from UK research councils (EPSRC, BBSRC) and the Children's Heart Surgery Fund.\nThe business has exclusive rights over several platform technologies in regenerative tissue engineering. Tissue Regenix is led by a team of highly experienced medical device industry veterans with a strong track record of translating early developmental work into products that are currently benefitting patients worldwide in a range of clinical settings from heart valves to orthopedic implants.\nTissue Regenix is focused on delivering its lead product, the dCELL Vascular Patch, into the clinic. Follow on products include the dCELL Meniscus, as well as an extensive pipeline of other product offerings in the vascular, cardiac and orthopedic areas.\nThe company is committed to pursuing the highest standards of product safety and quality and has retained world-class independent advisors to ensure the dCELL range meets or exceeds these.